PMID- 30150478 OWN - NLM STAT- MEDLINE DCOM- 20191010 LR - 20200511 IS - 1098-6596 (Electronic) IS - 0066-4804 (Print) IS - 0066-4804 (Linking) VI - 62 IP - 11 DP - 2018 Nov TI - Argentilactone Molecular Targets in Paracoccidioides brasiliensis Identified by Chemoproteomics. LID - 10.1128/AAC.00737-18 [doi] LID - e00737-18 AB - Paracoccidioidomycosis (PCM) is the cause of many deaths from systemic mycoses. The etiological agents of PCM belong to the Paracoccidioides genus, which is restricted to Latin America. The infection is acquired through the inhalation of conidia that primarily lodge in the lungs and may disseminate to other organs and tissues. The treatment for PCM is commonly performed via the administration of antifungals such as amphotericin B, co-trimoxazole, and itraconazole. The antifungal toxicity and side effects, in addition to their long treatment times, have stimulated research for new bioactive compounds. Argentilactone is a compound that was isolated from the Brazilian savanna plant Hyptis ovalifolia, and it has been suggested to be a potent antifungal, inhibiting the dimorphism of P. brasiliensis and the enzymatic activity of isocitrate lyase, a key enzyme of the glyoxylate cycle. This work was developed due to the importance of elucidating the putative mode of action of argentilactone. The chemoproteomics approach via affinity chromatography was the methodology used to explore the interactions between P. brasiliensis proteins and argentilactone. A total of 109 proteins were identified and classified functionally. The most representative functional categories were related to amino acid metabolism, energy, and detoxification. Argentilactone inhibited the enzymatic activity of malate dehydrogenase, citrate synthase, and pyruvate dehydrogenase. Furthermore, argentilactone induces the production of reactive oxygen species and inhibits the biosynthesis of cell wall polymers. CI - Copyright (c) 2018 American Society for Microbiology. FAU - Silva, Livia do Carmo AU - Silva LDC AD - Laboratorio de Biologia Molecular, Instituto de Ciencias Biologicas, Universidade Federal de Goias, Goiania, Goias, Brazil. FAU - Tauhata, Sinji Borges Ferreira AU - Tauhata SBF AD - Laboratorio de Biologia Molecular, Instituto de Ciencias Biologicas, Universidade Federal de Goias, Goiania, Goias, Brazil. FAU - Baeza, Lilian Cristiane AU - Baeza LC AD - Laboratorio de Biologia Molecular, Instituto de Ciencias Biologicas, Universidade Federal de Goias, Goiania, Goias, Brazil. AD - Centro de Ciencias Medicas e Farmaceuticas, Universidade Estadual do Oeste do Parana, Cascavel, Parana, Brazil. FAU - de Oliveira, Cecilia Maria Alves AU - de Oliveira CMA AD - Laboratorio de Produtos Naturais, Instituto de Quimica, Universidade Federal de Goias, Goiania, Brazil. FAU - Kato, Lucilia AU - Kato L AD - Laboratorio de Produtos Naturais, Instituto de Quimica, Universidade Federal de Goias, Goiania, Brazil. FAU - Borges, Clayton Luiz AU - Borges CL AD - Laboratorio de Biologia Molecular, Instituto de Ciencias Biologicas, Universidade Federal de Goias, Goiania, Goias, Brazil. FAU - de Almeida Soares, Celia Maria AU - de Almeida Soares CM AD - Laboratorio de Biologia Molecular, Instituto de Ciencias Biologicas, Universidade Federal de Goias, Goiania, Goias, Brazil. FAU - Pereira, Maristela AU - Pereira M AD - Laboratorio de Biologia Molecular, Instituto de Ciencias Biologicas, Universidade Federal de Goias, Goiania, Goias, Brazil maristelaufg@gmail.com. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20181024 PL - United States TA - Antimicrob Agents Chemother JT - Antimicrobial agents and chemotherapy JID - 0315061 RN - 0 (Antifungal Agents) RN - 0 (Lactones) RN - 0 (argentilactone) RN - 304NUG5GF4 (Itraconazole) RN - 7XU7A7DROE (Amphotericin B) SB - IM MH - A549 Cells MH - Amphotericin B/pharmacology MH - Antifungal Agents/*pharmacology MH - Brazil MH - Cell Line, Tumor MH - Cell Wall/drug effects MH - Humans MH - Itraconazole/pharmacology MH - Lactones/*pharmacology MH - Paracoccidioides/*drug effects MH - Paracoccidioidomycosis/*drug therapy PMC - PMC6201122 OTO - NOTNLM OT - Paracoccidioides OT - antifungal OT - argentilactone OT - chemoproteomics OT - drug discovery OT - targets EDAT- 2018/08/29 06:00 MHDA- 2019/10/11 06:00 PMCR- 2019/04/24 CRDT- 2018/08/29 06:00 PHST- 2018/04/18 00:00 [received] PHST- 2018/08/17 00:00 [accepted] PHST- 2018/08/29 06:00 [pubmed] PHST- 2019/10/11 06:00 [medline] PHST- 2018/08/29 06:00 [entrez] PHST- 2019/04/24 00:00 [pmc-release] AID - AAC.00737-18 [pii] AID - 00737-18 [pii] AID - 10.1128/AAC.00737-18 [doi] PST - epublish SO - Antimicrob Agents Chemother. 2018 Oct 24;62(11):e00737-18. doi: 10.1128/AAC.00737-18. Print 2018 Nov.